# Predicting Clinical Efficacy of Immunotherapy Using Pre-treatment andContinuousMonitoring of PD-L1 TPS/CPS on CTCs, and Immunity Exhaustion Scores

> **NCT07396259** · — · RECRUITING · sponsor: **Chang Gung Memorial Hospital** · enrollment: 150 (estimated)

## Conditions studied

- Circulating Tumor Cells (CTCs)
- Immunotherapy
- PD-L1 Expression
- Liquidbiopsies

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT07396259
- **Lead sponsor:** Chang Gung Memorial Hospital
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** RECRUITING
- **Start date:** 2025-02-25
- **Primary completion:** 2030-12-31
- **Final completion:** 2030-12-31
- **Target enrollment:** 150 (ESTIMATED)
- **Last updated:** 2026-02-09


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07396259

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07396259, "Predicting Clinical Efficacy of Immunotherapy Using Pre-treatment andContinuousMonitoring of PD-L1 TPS/CPS on CTCs, and Immunity Exhaustion Scores". Retrieved via AI Analytics 2026-05-24 from https://api.ai-analytics.org/clinical/NCT07396259. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*